Sanara MedTech (SMTI) Operating Margin (2010 - 2026)

Sanara MedTech has reported Operating Margin for 16 years, with the latest figure at 9.52% in Q1 2026.

• For the quarter ending Q1 2026, Operating Margin rose 600.0% year-over-year to 9.52%; the trailing twelve-month figure through Mar 2026 stood at 6.15% (up 508.0% YoY), and the FY2025 full-year result was 7.08%, up 563.0% from the prior year.
• Operating Margin for Q1 2026 stood at 9.52%, up from 3.81% in the prior quarter.
• The five-year high for Operating Margin was 42.71% in Q4 2022, with the low at 35.55% in Q1 2022.
• Historically, Operating Margin has averaged 3.63% across 5 years, with a median of 1.28% in 2023.
• The largest YoY upside for Operating Margin was 2771 bps in 2023 against a maximum downside of 4399 bps in 2023.
• Sanara MedTech's Operating Margin stood at 42.71% in 2022, then sank by 103 bps to 1.28% in 2023, then jumped by 773 bps to 8.59% in 2024, then plunged by 56 bps to 3.81% in 2025, then soared by 150 bps to 9.52% in 2026.
• The last three Operating Margin figures came in at 9.52% (Q1 2026), 3.81% (Q4 2025), and 11.17% (Q3 2025), per Business Quant data.